Construct: Phosphoacceptor residues at the eight consensus sites within the coding region are replaced with a nonphosphorylatable amino acid, alanine. Expression is driven by an sev promoter.
aopACT.sev mutants exhibit a rough eye phenotype.
Flies carrying aopACT.sev have a rough eye phenotype.
Mutants show reduced number of R7 photoreceptors.
Flies have rough eyes characterized by the loss of the R3, R4 and R7 photoreceptor neurons and the nonneuronal cone cells.
Eyes are slightly smaller than wild type with a rough appearance, photoreceptors R3, R4 and R7 fail to develop. Also an increase in cell death in eye tissue.
aopACT.sev has decreased cell number | adult stage phenotype, enhanceable by pntp2
aopACT.sev has visible | adult stage phenotype, enhanceable by pntp2
aopACT.sev has decreased cell number | adult stage phenotype, enhanceable by pntp3
aopACT.sev has visible | adult stage phenotype, enhanceable by pntp3
aopACT.sev has decreased cell number | adult stage phenotype, enhanceable by pntp2p3
aopACT.sev has visible phenotype, enhanceable by edlUAS.Tag:MYC/Scer\GAL4hs.2sev
aopACT.sev has visible phenotype, enhanceable by edl[+]/edlk06602
aopACT.sev has visible phenotype, enhanceable by edlunspecified
aopACT.sev is an enhancer of visible phenotype of lzts1
aopACT.sev, sevS11.Tag:MYC has viable phenotype
aopACT.sev has eye photoreceptor cell | adult stage | decreased number phenotype, enhanceable by pntp2
aopACT.sev has eye phenotype, enhanceable by pntp2
aopACT.sev has eye photoreceptor cell | adult stage | decreased number phenotype, enhanceable by pntp3
aopACT.sev has eye phenotype, enhanceable by pntp3
aopACT.sev has eye photoreceptor cell | adult stage | decreased number phenotype, enhanceable by pntp2p3
aopACT.sev has eye phenotype, enhanceable by edlUAS.Tag:MYC/Scer\GAL4hs.2sev
aopACT.sev has eye phenotype, enhanceable by edl[+]/edlk06602
aopACT.sev has eye phenotype, enhanceable by edlunspecified
aopACT.sev has ommatidium phenotype, enhanceable by edlunspecified
aopACT.sev has eye phenotype, enhanceable by EY2-5AH425
aopACT.sev has eye phenotype, enhanceable by EY2-6AC403
aopACT.sev has eye phenotype, enhanceable by EY2-6AQR618
aopACT.sev has eye phenotype, enhanceable by EY3-4x1S805
aopACT.sev has eye phenotype, enhanceable by EY3-4xII790
aopACT.sev has eye phenotype, enhanceable by EY3-5xKR845
aopACT.sev has eye phenotype, enhanceable by EY3-5xZB970
aopACT.sev has eye phenotype, enhanceable by SBA651
aopACT.sev has eye phenotype, enhanceable by SU132
aopACT.sev has eye phenotype, enhanceable by SosD120
aopACT.sev has eye phenotype, enhanceable by SosxB10
aopACT.sev has eye phenotype, enhanceable by eyaA188
aopACT.sev has eye phenotype, enhanceable by eyaG130
aopACT.sev has eye phenotype, enhanceable by retnB142
aopACT.sev has eye phenotype, enhanceable by retnx1N793
aopACT.sev has eye phenotype, enhanceable by pntAF397
aopACT.sev has eye phenotype, enhanceable by pntAP553
aopACT.sev has eye phenotype, enhanceable by rlA0648
aopACT.sev has eye phenotype, enhanceable by spenAH393
aopACT.sev has eye phenotype, enhanceable by spenBU720
aopACT.sev has phenotype, enhanceable by SosEY2-3
aopACT.sev has phenotype, non-enhanceable by lilliXS407
aopACT.sev has phenotype, non-enhanceable by lilliXS575
aopACT.sev has phenotype, non-enhanceable by lillis35
aopACT.sev has phenotype, non-enhanceable by EY2-5DW1080
aopACT.sev has phenotype, non-enhanceable by EY2-8xCB204
aopACT.sev has phenotype, non-enhanceable by EY3-2xAZ145
aopACT.sev has phenotype, non-enhanceable by EY3-2xCF301
aopACT.sev has phenotype, non-enhanceable by EY3-2xDF411
aopACT.sev has phenotype, non-enhanceable by EY3-3xBE183
aopACT.sev has phenotype, non-enhanceable by EY3-3xF6
aopACT.sev has phenotype, non-enhanceable by Su(Tpl)DI998
aopACT.sev has phenotype, non-enhanceable by Su(Tpl)EZ1217
aopACT.sev has phenotype, non-enhanceable by lilliDE884
aopACT.sev has phenotype, non-enhanceable by lilliDR999
aopACT.sev has phenotype, non-enhanceable by Sin3ACY886
aopACT.sev has phenotype, non-enhanceable by Sin3ADW1046
aopACT.sev has phenotype, non-enhanceable by glDZ1053
aopACT.sev has phenotype, non-enhanceable by glER1085
aopACT.sev has phenotype, non-enhanceable by EY2-8EP1160
aopACT.sev has eye phenotype, suppressible by aopACT.sev
aopACT.sev has photoreceptor cell R7 phenotype, suppressible by edslH8/ed1X5
aopACT.sev has ommatidium phenotype, suppressible by edslH8/ed1X5
aopACT.sev has eye phenotype, suppressible by Taf4AG456
aopACT.sev has eye phenotype, suppressible by Taf4I53
aopACT.sev has eye phenotype, suppressible by stgD115
aopACT.sev has eye phenotype, suppressible by stgDD937
aopACT.sev has phenotype, non-suppressible by lilliXS407
aopACT.sev has phenotype, non-suppressible by lillis35
aopACT.sev has phenotype, non-suppressible by lilliXS575
aopACT.sev has phenotype, non-suppressible by EY3-3xF6
aopACT.sev has phenotype, non-suppressible by Su(Tpl)DI998
aopACT.sev has phenotype, non-suppressible by Su(Tpl)EZ1217
aopACT.sev has phenotype, non-suppressible by lilliDE884
aopACT.sev has phenotype, non-suppressible by lilliDR999
aopACT.sev has phenotype, non-suppressible by Sin3ACY886
aopACT.sev has phenotype, non-suppressible by Sin3ADW1046
aopACT.sev has phenotype, non-suppressible by glDZ1053
aopACT.sev has phenotype, non-suppressible by glER1085
aopACT.sev has phenotype, non-suppressible by EY2-5DW1080
aopACT.sev has phenotype, non-suppressible by EY2-8EP1160
aopACT.sev has phenotype, non-suppressible by EY2-8xCB204
aopACT.sev has phenotype, non-suppressible by EY3-2xAZ145
aopACT.sev has phenotype, non-suppressible by EY3-2xCF301
aopACT.sev has phenotype, non-suppressible by EY3-2xDF411
aopACT.sev has phenotype, non-suppressible by EY3-3xBE183
aopACT.sev is an enhancer of eye phenotype of lzts1
aopACT.sev is a suppressor of eye phenotype of aopACT.sev
aopACT.sev, rlAL528 has eye phenotype
A CblK26 heterozygous background rescues the rough eye phenotype found in aopACT.sev mutants.
The rough eye phenotype caused by aopACT.sev is enhanced if the flies also carry edlk06602/+. The rough eye phenotype caused by aopACT.sev is enhanced by expression of edlScer\UAS.T:Hsap\MYC under the control of Scer\GAL4hs.2sev.
Dominant activated form of aop.